# Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye

> **NCT01387347** · PHASE2 · COMPLETED · sponsor: **ReGenTree, LLC** · enrollment: 72 (actual)

## Conditions studied

- Dry Eye Syndrome
- Dry Eye

## Interventions

- **DRUG:** Thymosin beta 4
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01387347
- **Lead sponsor:** ReGenTree, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387347, "Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01387347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*